RAC 2.23% $1.75 race oncology ltd

Ann: Race Develops Improved IV Formulation of Zantrene, page-19

  1. 90 Posts.
    lightbulb Created with Sketch. 13
    Dr T has confirmed somewhere else that new safety trials are not required and it can use the old data under the 505(b)(2) pathway.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.75
Change
-0.040(2.23%)
Mkt cap ! $297.9M
Open High Low Value Volume
$1.79 $1.79 $1.72 $146.2K 83.61K

Buyers (Bids)

No. Vol. Price($)
1 2901 $1.73
 

Sellers (Offers)

Price($) Vol. No.
$1.75 994 1
View Market Depth
Last trade - 16.10pm 17/06/2024 (20 minute delay) ?
Last
$1.74
  Change
-0.040 ( 1.51 %)
Open High Low Volume
$1.76 $1.77 $1.72 23546
Last updated 15.56pm 17/06/2024 ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.